April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Signaling Pathways in Downregulation of Keratan Sulfate Proteoglycans in Activated Corneal Keratocytes
Author Affiliations & Notes
  • N. Sundarraj
    Ophthalmology Department, University of Pittsburgh School of Medicine, UPMC Eye Center, Eye and Ear Institute, Ophthalmology and Visual Science Research Center, Pittsburgh, Pennsylvania
  • J. Chen
    Ophthalmology Department, University of Pittsburgh School of Medicine, UPMC Eye Center, Eye and Ear Institute, Ophthalmology and Visual Science Research Center, Pittsburgh, Pennsylvania
  • E. Guerriero
    Ophthalmology Department, University of Pittsburgh School of Medicine, UPMC Eye Center, Eye and Ear Institute, Ophthalmology and Visual Science Research Center, Pittsburgh, Pennsylvania
  • P. Kinchington
    Ophthalmology Department, University of Pittsburgh School of Medicine, UPMC Eye Center, Eye and Ear Institute, Ophthalmology and Visual Science Research Center, Pittsburgh, Pennsylvania
  • Footnotes
    Commercial Relationships  N. Sundarraj, None; J. Chen, None; E. Guerriero, None; P. Kinchington, None.
  • Footnotes
    Support  Supported by NIH grants EY03263(NS), EY08098 (core grant), Research to Prevent Blindness and Eye and Ear Foundation of Pittsburgh, PA
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4541. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Sundarraj, J. Chen, E. Guerriero, P. Kinchington; Signaling Pathways in Downregulation of Keratan Sulfate Proteoglycans in Activated Corneal Keratocytes. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4541.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine whether Rho GTPases or MAPKs regulate TGF-β1 or b-FGF- induced downregulation of KSPGs (lumican and keratocan) in corneal stromal keratocytes.

Methods: : Keratocytes isolated from rabbit corneal stroma, plated in a serum free (SF) medium, were treated with b-FGF/heparin or TGF-β1 in the presence or absence of specific inhibitors of Rho, Rho kinase (ROCK) or MAPKs. In separate experiments keratocytes were infected with replication-defective inducible tet-off adenoviral vectors encoding cDNAs for dominant negative (DN) or constitutively active (CA) HA-tagged RhoA and expression of the recombinant proteins was induced during the activation of keratocytes with TGF-β1 or b-FGF. Specific phenotypic changes were analyzed by immunocytochemistry and western blotting, and the relative abundance of specific mRNAs was estimated by quantitative RT-PCR.

Results: : Immunocytochemical and western blot analyses indicated that in keratocytes activated with TGF-β1 and b-FGF, decreases in cell-associated and secreted KS were prevented by Rho or ROCK inhibition during the activation. While both TGF-β1 and b-FGF-induced downregulation of lumican mRNA levels was prevented by Rho and ROCK inhibition with C3 exoenzyme and Y27632, respectively, only b-FGF-induced downregulation of keratocan mRNA levels was prevented by Rho inhibition but not by ROCK-inhibition. Inhibition of Jun N-terminal kinase (JNK) with SP600125 during keratocyte activation prevented downregulation of lumican and keratocan mRNA. An overexpression of CA-RhoA during keratocyte activation had little effect on the downregulation of KSPGs. However, overexpression of DN-RhoA during TGF-β1 or b-FGF-induced activation prevented the downregulation of lumican.

Keywords: cornea: stroma and keratocytes • proteoglycans/glycosaminoglycans • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×